GB-5121

N/A

Report date: 2024/04/01 14:02:17
NME

Base Information

Drug NameGB-5121
Drug Alias NameGB-5121GB5121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsCentral Nervous System LymphomaNeurolymphomatosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[6
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesGossamer Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGossamer Bio Inc
Inactive CompaniesGB005 Inc
Active IndicationsNeurolymphomatosis
Inactive IndicationsCentral Nervous System Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A